Shuttle Pharmaceuticals Holdings (SHPH) Retained Earnings (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Retained Earnings of $51.8 million for Q1 2026, up 26.6% year-over-year from $40.9 million in Q1 2025, and up 211.88% quarter-over-quarter from -$46.3 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Retained Earnings (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Retained Earnings history runs 6 years deep, the most recent figure standing at $51.8 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 26.6% year-over-year to $51.8 million; the TTM figure through Mar 2026 stood at $51.8 million (up 26.6% YoY), while the FY2025 annual figure was -$46.3 million, down 231.21% from the prior year.
- Retained Earnings for Q1 2026 stood at $51.8 million, up from -$46.3 million in the prior quarter.
- The five-year high for Retained Earnings was $51.8 million in Q1 2026, with the low at -$46.3 million in Q4 2025.
- The 5-year median for Retained Earnings is $29.5 million (2023), against an average of $14.5 million.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings tumbled 256.17% in 2022, then soared 461.03% in 2023.
- Shuttle Pharmaceuticals Holdings' Retained Earnings stood at -$18.8 million in 2022, then soared by 256.52% to $29.5 million in 2023, then increased by 19.66% to $35.3 million in 2024, then tumbled by 231.21% to -$46.3 million in 2025, then jumped by 211.88% to $51.8 million in 2026.
- Business Quant data shows SHPH's Retained Earnings at $51.8 million in Q1 2026, -$46.3 million in Q4 2025, and $45.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - | 51.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.80 Mn |
| Dec 31, 2025 | -46.30 Mn |
| Sep 30, 2025 | 45.08 Mn |
| Jun 30, 2025 | -41.34 Mn |
| Mar 31, 2025 | 40.92 Mn |
| Dec 31, 2024 | 35.29 Mn |
| Sep 30, 2024 | 31.66 Mn |
| Jun 30, 2024 | 30.00 Mn |
| Mar 31, 2024 | 29.93 Mn |
| Dec 31, 2023 | 29.49 Mn |
| Sep 30, 2023 | 29.40 Mn |
| Jun 30, 2023 | 18.99 Mn |
| Mar 31, 2023 | -9.87 Mn |
| Dec 31, 2022 | -18.84 Mn |
| Sep 30, 2022 | -8.14 Mn |
| Dec 31, 2021 | 12.06 Mn |